amsacrine has been researched along with Leukemia, Smoldering in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofmann, WK | 1 |
| Heil, G | 1 |
| Zander, C | 1 |
| Wiebe, S | 1 |
| Ottmann, OG | 1 |
| Bergmann, L | 1 |
| Hoeffken, K | 1 |
| Fischer, JT | 1 |
| Knuth, A | 1 |
| Kolbe, K | 1 |
| Schmoll, HJ | 1 |
| Langer, W | 1 |
| Westerhausen, M | 1 |
| Koelbel, CB | 1 |
| Hoelzer, D | 1 |
| Ganser, A | 1 |
1 trial available for amsacrine and Leukemia, Smoldering
| Article | Year |
|---|---|
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Amsacrine; Anemia, Refractory, with Excess of Blasts; Antineoplastic Com | 2004 |